The price of teriparatide 20 mg injection can vary significantly depending on factors such as location, pharmacy, insurance coverage, and whether a generic version is available [1]. Teriparatide is a parathyroid hormone analog used to treat osteoporosis [2].
How much does teriparatide cost without insurance?
Without insurance, the retail price for a 20 mg/1.6 mL vial of teriparatide can range from approximately $800 to over $2,000. A common price point for a 28-day supply (e.g., four pens) often falls between $4,000 and $6,000 [1].
Are there lower-cost options for teriparatide?
Generic versions of teriparatide have become available, which can significantly reduce the cost compared to the brand-name product, Forteo [3]. These generics offer a more affordable treatment option for eligible patients [1].
How do teriparatide prices compare to other osteoporosis treatments?
The cost of teriparatide, even with generic options, is generally higher than many other osteoporosis medications, such as bisphosphonates or denosumab. However, it is considered a potent anabolic agent for severe osteoporosis and may be chosen when other treatments are insufficient or contraindicated [4].
When does teriparatide patent protection end?
Patent information for specific drugs like teriparatide can be complex, with multiple patents covering different aspects of the drug, its manufacturing, and its uses [5]. Information regarding the expiry of patents for teriparatide and its formulations can be found through resources like DrugPatentWatch.com [5]. The availability of generic versions is often contingent upon patent expiry and regulatory approval.
What is the typical dosage and administration of teriparatide?
Teriparatide is typically administered as a subcutaneous injection of 20 mcg (which is 20 mg per mL concentration, but the dose is in mcg) once daily for up to 24 months. The injection is usually given into the thigh or abdomen [2].
What are the potential side effects of teriparatide?
Common side effects of teriparatide can include nausea, joint pain, headache, and dizziness. Less common but serious side effects may include an increased risk of osteosarcoma, particularly in patients with Paget's disease of bone or unexplained elevations of alkaline phosphatase, and hypercalcemia [2].
Who manufactures teriparatide?
The brand-name teriparatide, Forteo, was originally developed by Eli Lilly and Company. Following patent expirations and the introduction of generic versions, several other pharmaceutical companies now manufacture and market generic teriparatide products [3].
Sources:
[1] https://www.goodrx.com/teriparatide
[2] https://www.ncbi.nlm.nih.gov/books/NBK556193/
[3] https://www.drugs.com/availability/teriparatide-injection.html
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831731/
[5] https://www.drugpatentwatch.com/